title: Reply: T-Cell Acute Lymphoblastic Leukemia, Minimal Residual Disease, and Lymphocyte Recovery.
authors.affiliation: Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, Los Angeles, California.|Keck School of Medicine, University of Southern California, Los Angeles, California.
authors.forename: Chintan
authors.initials: C
authors.lastname: Parekh
authors.affiliation: Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, Los Angeles, California.|Keck School of Medicine, University of Southern California, Los Angeles, California.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Gaynon
authors.affiliation: Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, Los Angeles, California.|Keck School of Medicine, University of Southern California, Los Angeles, California.
authors.forename: Hisham
authors.initials: H
authors.lastname: Abdel-Azim
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012074:Remission Induction